 |
13 Diseases |  |
0 Trials |
|
0 Trials |  |
20 News |  |
- | Xopenex HFA (levalbuterol tartrate) / Sumitomo Dainippon
Reimbursement, Journal, Medicaid: Trends in Medicaid spending on inhalers in the United States, 2012-2018. (Pubmed Central) - Dec 16, 2021
The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.
- Xopenex HFA (levalbuterol tartrate) / Sumitomo Pharma
Trial primary completion date: A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects (clinicaltrials.gov) - Feb 3, 2016
P3, N=18, Terminated, Sponsor: Sunovion
The authors declare no conflicts of interest. Trial primary completion date: Jul 2016 --> Dec 2014
- Xopenex HFA (levalbuterol tartrate) / Sumitomo Pharma
Enrollment change, Trial termination: A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects (clinicaltrials.gov) - Apr 18, 2015
P3, N=18, Terminated, Sponsor: Sunovion
Trial primary completion date: Jul 2016 --> Dec 2014 N=120 --> 18 | Recruiting --> Terminated
- |||||| Xopenex HFA (levalbuterol tartrate) / Sumitomo Pharma
Enrollment open: A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects (clinicaltrials.gov) - Jul 27, 2014
P3, N=120, Recruiting, Sponsor: Sunovion
N=120 --> 18 | Recruiting --> Terminated Not yet recruiting --> Recruiting
- |||||||||| Xopenex HFA (levalbuterol tartrate) / Sumitomo Pharma
New P3 trial: A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects (clinicaltrials.gov) - May 28, 2014
P3, N=120, Not yet recruiting, Sponsor: Sunovion
- ||||||| levalbuterol / Generic mfg.
Trial completion: Long Term Safety Study of Levalbuterol and Racemic Albuterol in Subjects Twelve Years of Age and Older With Asthma (clinicaltrials.gov) - Feb 22, 2014
P3, N=746, Completed, Sponsor: Sunovion
Not yet recruiting --> Recruiting No longer recruiting --> Completed
- ||||||| Xopenex HFA (levalbuterol tartrate) / Sumitomo Pharma
Trial completion: A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma (clinicaltrials.gov) - Jun 30, 2013
P3, N=198, Completed, Sponsor: Sunovion
No longer recruiting --> Completed Active, not recruiting --> Completed